TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

Shankar Siva; Brent Chesson; Mathias Bressel; David Pryor; Braden Higgs; Hayley M Reynolds; Nicholas Hardcastle; Rebecca Montgomery; Ben Vanneste; Vincent Khoo; Jeremy Ruben; Eddie Lau; Michael S Hofman; Richard De Abreu Lourenco; Swetha Sridharan; Nicholas R Brook; Jarad Martin; Nathan Lawrentschuk; Tomas Kron; Farshad Foroudi

Journal article

TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

Shankar Siva, Brent Chesson, Mathias Bressel, David Pryor, Braden Higgs, Hayley M Reynolds, Nicholas Hardcastle, Rebecca Montgomery, Ben Vanneste, Vincent Khoo, Jeremy Ruben, Eddie Lau, Michael S Hofman, Richard De Abreu Lourenco, Swetha Sridharan, Nicholas R Brook, Jarad Martin, Nathan Lawrentschuk, Tomas Kron, Farshad Foroudi

BMC Cancer | BMC | Published : 2018

DOI: 10.1186/s12885-018-4916-2

University of Melbourne Researchers

Michael Hofman Author Medicine - St Vincent's Hospital

Farshad Foroudi Author Clinical Pathology

Nathan Lawrentschuk Author Surgery - Austin Health

Eddie Lau Author Radiology

Tomas Kron Author The Sir Peter MacCallum Department of Oncology

Related Projects (1)

Stereotactic Ablative Radiotherapy (Sabr) As A New Precision Treatment Option In Kidney Cancer

Grants

Awarded by National Health and Medical Research Council (NHMRC)

Funding Acknowledgements

This study underwent competitive peer review by the National Health and Medical Research Council (NHMRC) and was awarded governmental Cancer Australia funding (APP1139464). Additional seed funding and support for imaging substudies was provided by Varian (R) Industries.